Palladon Retard 4 mg
Palladon Retard 4 mg is a medicine authorised by Swissmedic under authorisation number 53223. The authorisation holder is Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch. The medicinal product code is Synthetic medicines and the dispensing category is A+: Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material. First authorisation was granted on 12 March 1996 and the authorisation is valid without a time limit. ATC code N02AA03 places the medicine in the group Analgesics.
| Authorisation number | 53223 |
|---|---|
| Name | Palladon Retard 4 mg |
| Full name | Palladon Retard 4 mg, Retardkapseln |
| Authorisation holder | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A+ · Prescription with conditions |
| ATC code | N02AA03 |
| First authorisation | 12 March 1996 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Palladon Retard 4 mg, Retardkapseln | A+ | 12 March 1996 |
| 2 | Palladon Retard 8 mg, Retardkapseln | A+ | 12 March 1996 |
| 3 | Palladon Retard 16 mg, Retardkapseln | A+ | 12 March 1996 |
| 4 | Palladon Retard 24 mg, Retardkapseln | A+ | 12 March 1996 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 109 | 30 | Kapsel(n) | N02AA03 | 01.01.3. | A+ |
| 117 | 60 | Kapsel(n) | N02AA03 | 01.01.3. | A+ |
| 125 | 30 | Kapsel(n) | N02AA03 | 01.01.3. | A+ |
| 133 | 60 | Kapsel(n) | N02AA03 | 01.01.3. | A+ |
| 141 | 30 | Kapsel(n) | N02AA03 | 01.01.3. | A+ |
| 168 | 60 | Kapsel(n) | N02AA03 | 01.01.3. | A+ |
| 176 | 30 | Kapsel(n) | N02AA03 | 01.01.3. | A+ |
| 184 | 60 | Kapsel(n) | N02AA03 | 01.01.3. | A+ |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Palladon Retard 4 mg authorised in Switzerland?
Yes. Palladon Retard 4 mg is authorised by Swissmedic under authorisation number 53223, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Palladon Retard 4 mg have?
Palladon Retard 4 mg is in dispensing category A+. Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material.
Who is the authorisation holder of Palladon Retard 4 mg?
The authorisation holder is Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.